For research use only. Not for therapeutic Use.
(±)-N-3-Benzylnirvanol is a racemic mixture of (+)-N-3-Benzylnirvanol and (-)-N-3-Benzylnirvanol. (+)-N-3-Benzylnirvanol and (–)-N-3-Benzylnirvanol are potent and selective cytochrome P450 inhibitors with Ki values of 0.25 and 5.3 μM for CYP2C19, respectively[1].
| Catalog Number | R007144 |
| CAS Number | 93879-40-4 |
| Synonyms | 3-benzyl-5-ethyl-5-phenylimidazolidine-2,4-dione |
| Molecular Formula | C18H18N2O2 |
| Purity | ≥95% |
| InChI | InChI=1S/C18H18N2O2/c1-2-18(15-11-7-4-8-12-15)16(21)20(17(22)19-18)13-14-9-5-3-6-10-14/h3-12H,2,13H2,1H3,(H,19,22) |
| InChIKey | ZMZDHUHMXXALFX-UHFFFAOYSA-N |
| SMILES | CCC1(C(=O)N(C(=O)N1)CC2=CC=CC=C2)C3=CC=CC=C3 |
| Reference | [1]. Hisashi Suzuki, et al. (+)-N-3-Benzyl-nirvanol and (-)-N-3-benzyl-phenobarbital: new potent and selective in vitro inhibitors of CYP2C19. Drug Metab Dispos. 2002 Mar;30(3):235-9. |
